April 20, 2022Nephrology Dialysis Transplantation71 citationsOpen Access
View Full PaperKidney outcomes with finerenone: an analysis from the FIGARO-DKD study
Structured PICO
Does finerenone reduce kidney disease progression and cardiovascular events in patients with T2D and early- or late-stage CKD?
P
Population
patients with T2D and early- or late-stage CKD
I
Intervention
finerenone
O
Outcome
kidney disease progression and cardiovascular eventshard clinical
Finerenone demonstrates protective effects against kidney disease progression and cardiovascular events in patients with T2D and CKD.
Abstract
The present analyses suggest that finerenone protects against kidney disease progression and cardiovascular events in patients with T2D and early- or late-stage CKD.